Skip to main content
. 2021 Sep 30;12:736036. doi: 10.3389/fimmu.2021.736036

Figure 2.

Figure 2

Cumulative incidence of autoimmune diseases in PPI and non-PPI users. (A) Cumulative incidence of overall ADs for PPI and non-PPI users (B) Cumulative incidence of systemic ADs for PPI users and non-PPI users (C) Cumulative incidence of ADs in PPI users and non-PPI users. AD, autoimmune diseases. PPI, proton pump inhibitor.